首页 | 本学科首页   官方微博 | 高级检索  
检索        

两亲性壳聚糖包覆紫杉醇脂质体的制备及体外释放研究
引用本文:刁雨辉,霍美蓉,吕 霖,周建平.两亲性壳聚糖包覆紫杉醇脂质体的制备及体外释放研究[J].药学与临床研究,2012,20(6):490-494.
作者姓名:刁雨辉  霍美蓉  吕 霖  周建平
作者单位:1. 南京市鼓楼医院,南京,210009
2. 中国药科大学药剂教研室,南京,210009
摘    要:目的:制备两亲性壳聚糖N-辛基-N,O-羧甲基壳聚糖包覆紫杉醇脂质体(PTX-LP-OCC),并考察其理化性质及体外释放行为。方法:采用基于乙醇的前体脂质体法制备紫杉醇脂质体并以OCC包覆,并以普通脂质体(PTX-LP)为对照,测定其包封率、粒径大小、电位,观测其形态及稳定性,然后采用全体液平衡反向透析法研究体外释放行为。结果:紫杉醇脂质体包封率为89.5%,粒径为236.5 nm,Zeta电位为-31.4 mV,多糖包覆修饰后药物包封率无显著变化,粒径及Zeta电位显著增加,脂质体稳定性显著提高,药物释放呈缓释特征,且突释显著降低。结论:两亲性壳聚糖包覆脂质体是一个有前景的抗肿瘤药物递送载体

关 键 词:两亲性壳聚糖  脂质体  紫杉醇  药物泄漏  体外释放
收稿时间:2012/9/19 0:00:00
修稿时间:2012/10/15 0:00:00

Preparation and in vitro Release of Paclitaxel Loaded Liposomes Modified with Amphiphilic Chitosan Derivatives
DIAO Yu-hui,HUO Mei-rong,Lv Lin and ZHOU Jian-ping.Preparation and in vitro Release of Paclitaxel Loaded Liposomes Modified with Amphiphilic Chitosan Derivatives[J].Pharmacertical and Clinical Research,2012,20(6):490-494.
Authors:DIAO Yu-hui  HUO Mei-rong  Lv Lin and ZHOU Jian-ping
Institution:1 Gulou Hospital,Nanjing 210008,China;2 Department of Pharmaceutics,School of Pharmaceutical Sciences,China Pharmaceutical University,Nanjing 210009,China
Abstract:Objective: To prepare paclitaxel loaded liposomes modified with amphiphilic chitosan deirvatives (N-octyl-N,O-carboxymethyl chitosan, OCC), and investigate their characteristics and release behavior in vitro. Methods: Paclitaxel loaded liposomes modified with or without OCC (PTX-LP, PTX-LP-OCC) were prepared using an ethanol-based proliposome technology. Particle size and zeta potential of the liposomes were determined with Zetasizer 3000 HSa. The morphology was observed by a transmission electron microscope (TEM) technology. Stability of liposomes was evaluated by determining the particle size and drug leakage from liposomes. Finally, the in vitro release profiles of paclitaxel from PTX-LP and PTX-LP-OCC were evaluated using the bulk-equilibrium reverse dialysis bag technique. Results: Paclitaxel loaded liposomes were successfully prepared with an average diameter of 236.5 nm and zeta potential of -31.4 mV. The encapsulation efficiency was 89.5%. After OCC modification, there was no significant change in encapsulation efficiency, but the particle size and zeta potential significantly increased. As compared to PTX-LP, PTX-LP-OCC possessed better stability and lower burst release. Conclusion: Liposome modified with amphiphilic chitosan derivatives is a promising carrier for anticancer drug delivery.
Keywords:Amphiphilic chitosan  Liposome  Paclitaxel  Drug leakage  In vitro release
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《药学与临床研究》浏览原始摘要信息
点击此处可从《药学与临床研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号